PPT Slide

Financial Summary: Q3 2000(in thousands, except per share amounts)

• R & D expense $4,872
  • Reimbursed by Pharmacia 3,704
  • R & D expense - net 1,168

• G & A expense 2,003

• Other income & expenses - net 521

• Net loss $2,628

• Net loss per share - basic & diluted $ 0.11

• Cash Balance at September 30, 2000 $20,596

Previous slide

Next slide

Back to first slide

View graphic version